Mesenchymal Stem Cells-Derived Exosomal miR-223-3p Alleviates Ocular Surface Damage and Inflammation by Downregulating Fbxw7 in Dry Eye Models
Investigative Ophthalmology & Visual Science · 2024
DOI: 10.1167/iovs.65.12.1 ↗At a glance
Journal article in Investigative Ophthalmology & Visual Science, 2024. Written by Guifang Wang and 4 co-authors. Institution: Ophthalmology Department, Loudi Central Hospital, Loudi, Hunan, China. Major MEDLINE topics: MicroRNAs, Dry Eye Syndromes, Disease Models, Animal, Exosomes. Cited 28 times so far (Crossref); 41 references. The full text is freely available (open access, CC BY-NC-ND 4.0).
Abstract (original language)
Purpose
Our previous study indicated that exosomes derived from mouse adipose-derived mesenchymal stem cells (mADSC-Exos) alleviated the benzalkonium chloride (BAC)-induced mouse dry eye model. However, the specific active molecules in mADSC-Exos that contribute to anti-dry eye therapy remain unidentified. In this study, we aimed to investigate the efficacy and mechanisms of miR-223-3p derived from mADSC-Exos in dry eye models.
Methods
Enzyme-linked immunosorbent assay (ELISA) experiments were conducted to determine miR-223-3p derived from mADSC-Exos that exerted anti-inflammatory effects on hyperosmolarity-induced mouse corneal epithelial cells (MCECs). The therapeutic efficacy of miR-223-3p was evaluated in mice with dry eye induced by either BAC or scopolamine (Scop). Mice were randomly assigned to 5 groups: sham, model, miR-223-3p overexpression, miR-223-3p knockdown, and 0.1% pranoprofen (positive group). Post-treatment, the severity of dry eye symptoms, and the pro-inflammatory cytokine levels were assessed. The effect of miR-223-3p on silencing the target gene was verified using ELISA and dual luciferase reporter assays.
Results
The mADSC-Exos that knocked out miR-223-3p did not reduce interleukin (IL)-6 content. Supplementing with miR-223-3p could restore the reduction of IL-6. The miR-223-3p effectively ameliorated ocular surface damage and decreased pro-inflammatory cytokines or chemokines in both BAC- and Scop-induced mouse dry eye models. Furthermore, miR-223-3p inhibited cell apoptosis. F-box and WD repeat domain-containing 7 (Fbxw7) was the potential direct target of miR-223-3p. The miR-223-3p suppressed the 3'-untranslated region of Fbxw7. The Fbxw7 knockdown suppressed hyperosmolarity-induced inflammation in MCECs.
Conclusions
The mADSC-derived exosomal miR-223-3p mitigates ocular surface damage and inflammation, indicating its potential as a promising treatment option for dry eye.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Ophthalmology Department, Loudi Central Hospital, Loudi, Hunan, China.
Cite
APA
Wang, G., Zhu, Y., Liu, Y., Yang, M., & Zeng, L. (2024). Mesenchymal Stem Cells-Derived Exosomal miR-223-3p Alleviates Ocular Surface Damage and Inflammation by Downregulating Fbxw7 in Dry Eye Models. Investigative Ophthalmology & Visual Science. https://doi.org/10.1167/iovs.65.12.1
Vancouver
Wang G, Zhu Y, Liu Y, Yang M, Zeng L. Mesenchymal Stem Cells-Derived Exosomal miR-223-3p Alleviates Ocular Surface Damage and Inflammation by Downregulating Fbxw7 in Dry Eye Models. Investigative Ophthalmology & Visual Science. 2024. doi:10.1167/iovs.65.12.1
BibTeX
@article{Wang2024,
author = {Wang, Guifang and Zhu, Yujie and Liu, Yuzhen and Yang, Mulin and Zeng, Li},
title = {Mesenchymal Stem Cells-Derived Exosomal miR-223-3p Alleviates Ocular Surface Damage and Inflammation by Downregulating Fbxw7 in Dry Eye Models},
journal = {Investigative Ophthalmology & Visual Science},
year = {2024},
doi = {10.1167/iovs.65.12.1}
}
EUVIMED